First AD

Second AD

Final Insights: Emerging role of MRD and ctDNA testing in Colon Cancer

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

Updates in CRC: Applying Evidence to Clinical Practice

OncLive Insights

Panelists discuss how Minimal Residual Disease (MRD) and circulating tumor DNA (ctDNA) testing are revolutionizing colon cancer management through improved risk stratification, treatment selection, and surveillance strategies.

Starting with a Patient Case: 45yM high-risk T4N0 resected CRC - What are next steps?

Patient Centered Approach: Important Patient Counseling Points regarding ctDNA results in CRC

Expert Perspectives: GALAXY Results from CIRUCLATE study - Is it Practice Changing?

Understanding ctDNA in Resected CRC: Transient vs. Sustained Clearance & Clinical Implications

Practical Considerations: Complexities with Utilizing ctDNA in CRC in the Real-World Practice Setting

Exploring the NICHE-2 Trial: Neoadjuvant Immunotherapy in dMMR Colon Cancer